GlassScriptPhysician profile
Kimberly A Aho
NPI 1154325173
$1,682.84
in general payments reported to CMS, 2019-2025
46 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $269 · 2021: $204 · 2022: $224 · 2023: $219 · 2024: $269 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $101.57 | 2019-2025 | Qulipta |
| Upsher-Smith Laboratories LLC | $97.93 | 2019-2021 | |
| Eisai INC. | $90.30 | 2020-2025 | |
| Lundbeck LLC | $85.62 | 2021-2025 | Rexulti, Vyepti |
| Ucb, INC. | $73.66 | 2020-2025 | Nayzilam, Zilbrysq, Fintepla |
| Novartis Pharmaceuticals Corporation | $69.03 | 2019-2024 | |
| Biogen, INC. | $54.73 | 2019-2025 | Vumerity |
| Argenx US, INC. | $53.72 | 2023-2024 | Vyvgart, Vyvgart Hytrulo |
| Kyowa Kirin, INC. | $52.00 | 2020-2023 | Nourianz |
| Ge Healthcare | $46.82 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $45.68 | 2024-2025 | Lumryz |
| Allergan, INC. | $44.88 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $44.84 | 2019-2022 | |
| Harmony Biosciences LLC | $39.89 | 2020-2024 | |
| Merz Pharmaceuticals, LLC | $37.79 | 2024 | Xeomin |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Aho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.